Cytosolic and Plasma Membrane Circuitry of Beta Cell Redox Control: Role in Survival, Oxidative Defense and Insulin Secretion

β 细胞氧化还原控制的胞浆和质膜电路:在生存、氧化防御和胰岛素分泌中的作用

基本信息

  • 批准号:
    9285794
  • 负责人:
  • 金额:
    $ 32.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-06-19 至 2020-09-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We have identified a novel cytosolic-plasma membrane circuit of redox control, dependent on plasma membrane oxidoreductase NQO1 and the cytosolic NADPH-regulating enzyme NAD kinase, which regulates NAD(P)H/NADP+ ratio, level of reactive oxygen intermediates (ROI) and glucose-stimulated insulin secretion (GSIS) from pancreatic beta cells. Our Preliminary Data demonstrate the critical role of these pathways for beta cell function, survival, and GSIS. Furthermore, NQO1 participates in the glucose-dependent process of quinone redox cycling, which regulates cytosolic NADH/NAD+ ratio and enhances GSIS. NAD kinase, a novel NADPH- regulating enzyme, is responsible for the de novo production of NADPH and participates in the protection of beta cells from oxidative stress. NQO1 and NAD kinase are critical for normal cell function, and have not been characterized in pancreatic beta cells. We will employ over- expression or knockdown using shRNA and adenoviral vectors strategies as well as NQO1 knockout pancreatic islets to analyze the role of these components in beta cell intermediary metabolism. We will analyze the role of NQO1 and NAD kinase on the response of beta cells or islets to glucose or other stimulatory agents using a custom-made integrated electrochemical- confocal imaging platform to simultaneously study islet metabolism, respiration, and signaling. These studies will provide greater insight into the mechanism of redox signaling in regulating insulin secretion and identify novel targets for the development of therapeutics for type 2 diabetes.
描述(由申请人提供):我们已经确定了一种新的细胞溶质-质膜氧化还原控制回路,依赖于质膜氧化还原酶NQO 1和细胞溶质NADPH调节酶NAD激酶,其调节NAD(P)H/NADP+比率、活性氧中间体(ROI)水平和胰腺β细胞葡萄糖刺激的胰岛素分泌(GSIS)。我们的初步数据证明了这些通路对β细胞功能,存活和GSIS的关键作用。此外,NQO 1参与葡萄糖依赖的醌氧化还原循环过程,调节胞质NADH/NAD+比率并增强GSIS。NAD激酶是一种新的NADPH调节酶,负责NADPH的从头产生并参与保护β细胞免受氧化应激。NQO 1和NAD激酶对于正常细胞功能至关重要,并且尚未在胰腺β细胞中表征。我们将采用使用shRNA和腺病毒载体策略以及NQO 1敲除胰岛的过表达或敲减来分析这些组分在β细胞中间代谢中的作用。我们将分析NQO 1和NAD激酶对β细胞或胰岛对葡萄糖或其他刺激剂的反应的作用,使用定制的集成电化学共聚焦成像平台同时研究胰岛代谢,呼吸和信号传导。这些研究将为氧化还原信号在调节胰岛素分泌中的机制提供更深入的了解,并为2型糖尿病治疗药物的开发确定新的靶点。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAVIER CUEVAS其他文献

JAVIER CUEVAS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAVIER CUEVAS', 18)}}的其他基金

Risk factor convergence in the development of lacunar strokes and vascular cognitive impairment and dementia
腔隙性中风、血管性认知障碍和痴呆发生的危险因素趋同
  • 批准号:
    10043409
  • 财政年份:
    2020
  • 资助金额:
    $ 32.52万
  • 项目类别:
NICOTINIC RECEPTORS IN MAMMALIAN INTRACARDIAC NEURONS
哺乳动物心内神经元中的烟碱受体
  • 批准号:
    2897350
  • 财政年份:
    1999
  • 资助金额:
    $ 32.52万
  • 项目类别:
NICOTINIC RECEPTORS IN MAMMALIAN INTRACARDIAC NEURONS
哺乳动物心内神经元中的烟碱受体
  • 批准号:
    6390472
  • 财政年份:
    1999
  • 资助金额:
    $ 32.52万
  • 项目类别:
NICOTINIC RECEPTORS IN MAMMALIAN INTRACARDIAC NEURONS
哺乳动物心内神经元中的烟碱受体
  • 批准号:
    6184700
  • 财政年份:
    1999
  • 资助金额:
    $ 32.52万
  • 项目类别:

相似海外基金

Clinical application of boron-conjugated adenovirus vector for neutron capture therapy
硼缀合腺病毒载体中子捕获治疗的临床应用
  • 批准号:
    19K09482
  • 财政年份:
    2019
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Vascular-targeted gene therapy to block proliferation of smooth muscle cells using a novel adenovirus vector
使用新型腺病毒载体进行血管靶向基因治疗以阻止平滑肌细胞增殖
  • 批准号:
    2273599
  • 财政年份:
    2019
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Studentship
Gene therapy for diabetes mellitus based on the suppression of lipotoxicity using an improved adenovirus vector
使用改进的腺病毒载体抑制脂毒性的糖尿病基因治疗
  • 批准号:
    18K14964
  • 财政年份:
    2018
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanisms of induction of mucosal immunity by adenovirus vector vaccine
腺病毒载体疫苗诱导粘膜免疫的机制
  • 批准号:
    16K18873
  • 财政年份:
    2016
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Hemophilia B Gene Therapy via CRISPR/Cas9-Targeted Integration of the Factor IX Gene using Adenovirus Vector Delivery
使用腺病毒载体递送通过 CRISPR/Cas9 靶向整合因子 IX 基因进行 B 型血友病基因治疗
  • 批准号:
    9193681
  • 财政年份:
    2016
  • 资助金额:
    $ 32.52万
  • 项目类别:
Gene therapy for diabetes mellitus and gene function analysis using a novel adenovirus vector
使用新型腺病毒载体进行糖尿病基因治疗和基因功能分析
  • 批准号:
    15K18939
  • 财政年份:
    2015
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Innate immue response through glycolipids by adenovirus-vector
腺病毒载体通过糖脂产生先天免疫反应
  • 批准号:
    26450450
  • 财政年份:
    2014
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a novel method for highly efficient gene targeting by adenovirus vector on human naive pluripotent stem cells
开发一种通过腺病毒载体高效基因靶向人类幼稚多能干细胞的新方法
  • 批准号:
    26893253
  • 财政年份:
    2014
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Development of targeting adenovirus vector as boron carrier for boron neutron capture therapy
开发靶向腺病毒载体作为硼中子捕获疗法的硼载体
  • 批准号:
    26462183
  • 财政年份:
    2014
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of adenovirus vector lacking VA RNA genes for efficient microRNA expression
开发缺乏 VA RNA 基因的腺病毒载体以实现有效的 microRNA 表达
  • 批准号:
    24701021
  • 财政年份:
    2012
  • 资助金额:
    $ 32.52万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了